<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/A8025D32-2EFA-416A-B79C-BEFA6A379151"><gtr:id>A8025D32-2EFA-416A-B79C-BEFA6A379151</gtr:id><gtr:name>RWTH Aachen University</gtr:name><gtr:address><gtr:line1>Pallwelsstr. 30</gtr:line1><gtr:line4>Aachen</gtr:line4><gtr:line5>D-52056</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:department>Clinical and Experimental Medicine</gtr:department><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A8025D32-2EFA-416A-B79C-BEFA6A379151"><gtr:id>A8025D32-2EFA-416A-B79C-BEFA6A379151</gtr:id><gtr:name>RWTH Aachen University</gtr:name><gtr:address><gtr:line1>Pallwelsstr. 30</gtr:line1><gtr:line4>Aachen</gtr:line4><gtr:line5>D-52056</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/464D389D-37E8-4F35-8E73-3DE6F1D2DA17"><gtr:id>464D389D-37E8-4F35-8E73-3DE6F1D2DA17</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>Harvey</gtr:otherNames><gtr:surname>Adams</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/6CADC6A9-31BB-4315-A6E1-78AA45BF36E3"><gtr:id>6CADC6A9-31BB-4315-A6E1-78AA45BF36E3</gtr:id><gtr:firstName>Patricia</gtr:firstName><gtr:otherNames>F</gtr:otherNames><gtr:surname>Lalor</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0700301"><gtr:id>CD111755-9AE0-48BC-A3C2-997EF3809F9B</gtr:id><gtr:title>Trafficking of monocytes and their differentiation to dendritic cells and macrophages in the human liver</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0700301</gtr:grantReference><gtr:abstractText>Most liver diseases occur as a consequence of uncontrolled inflammation mediated by white blood cells recruited into the liver from the blood. White blood cells enter the liver via channels or sinusoids that are lined by specialised cells called endothelial cells which the white cells must bind to and migrate between before they can enter liver tissue. We propose that this process will a) determine the nature of the cells recruited and b) determine how those cells become activated and thereby the outcome of liver injury. We have developed complex test tube models in which combinations of human liver cells are grown under particular conditions that mimic the environment within the diseased liver sinusoids. We will use these models to investigate how white cells are recruited and how interactions with sinusoidal cells can define the activation status of the cells during their recruitment. Understanding this process will elucidate why in some circumstances white blood cells can promote the repair of the damaged liver whereas in other circumstances they amplify liver injury. We hope to use this information to develop new therapies to manipulate white blood cells in the liver in favour of repair rather than continuing liver damage and thereby to reverse inflammatory liver disease and prevent liver cirrhosis.</gtr:abstractText><gtr:technicalSummary>Circulating monocytes gives rise to tissue-resident macrophages and dendritic cells which are critical regulators of inflammatory and immune-mediated responses. The liver contains functionally distinct macrophages and dendritic cells (DC) that contribute to local immune responses by activating immune responses or promoting inflammatory resolution. Thus activated DCs induce immune responses to pathogens whereas resting DCs induce tolerance; and although some activation pathways result in macrophages that drive immune-mediated liver injury others result in reparative macrophages that promote resolution. The balance of intrahepatic monocyte/macrophages activation will thus be a critical determinant in the outcome of liver injury. At least two phenotypically distinct subsets of monocytes circulate in blood which can be distinguished by their expression of specific cell surface markers. These cells enter the liver by migrating across sinusoidal endothelium and through the subendothelial matrix where they interact with other cells including fibroblasts and hepatocytes. We propose that the activation and differentiation of monocytes into liver DCs and macrophages will be shaped by interactions with sinusoidal endothelial cells during transmigration and then with matrix and parenchymal cells once the monocytes are in tissue. We have developed co-culture models using primary human liver cells that recapitulate the sinusoidal cellular environment in vitro. We will use these models to determine 1) the molecules involved in recruiting different subsets of monocytes from the blood into liver 2) the ability of underlying hepatocytes or fibroblasts to modulate this process in the presence of inflammatory stimuli 3) the effect of interactions with endothelium, subendothelial matrix and other liver cells on subsequent monocyte differentiation and activation. We hypothesise that migration through the multi-cellular hepatic sinusoids will confer on monocytes a distinct phenotype and function that will determine how these cells behave within liver tissue. Modulation of these processes may suggest ways in which monocyte recruitment and activation can be manipulated to favour resolution rather that persistence of inflammation in chronic liver disease.</gtr:technicalSummary><gtr:fund><gtr:end>2011-03-20</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-09-21</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>347503</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>RWTH Aachen University</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>University of Aachen</gtr:description><gtr:id>93C8157E-B9E3-4045-90C8-F80E584279E7</gtr:id><gtr:impact>Publications
Grants
Training</gtr:impact><gtr:partnerContribution>Scientific collaboration</gtr:partnerContribution><gtr:piContribution>Collaboration investigating leukocyte recruitment to the liver and in porviding research training for DFG funded clinical acdemics</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Inflammation Research (CIR)</gtr:department><gtr:description>Edinburgh</gtr:description><gtr:id>DC4E1D85-4A67-4838-A1F8-A932EF4CC667</gtr:id><gtr:impact>Ongoing publications and research collaborations</gtr:impact><gtr:partnerContribution>We have several ongoing collaborations sharing technology and expertise</gtr:partnerContribution><gtr:piContribution>We have developed a successful local collaboration with my colleague Dr Newsome andPorfs Forbes and Iredale in Edinburgh resulting an ongoing collaboration which ahs contributed to a recent MRC grant awarded in 2009.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>World hepatitis day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>8181E946-8B49-4981-8E93-EBAD17B10A6E</gtr:id><gtr:impact>-Hosted public meeting for World hepatitis day attended by patient groups, politicians, press. Featured on Kerrang Radio &amp;amp; Naked scientist website http://www.thenakedscientists.com/HTML/podcasts/specials/show/2009.06.10/

Increased profile</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>PSC</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7D7D4C9C-E931-4B48-ADBA-6EEF2BBEBFA1</gtr:id><gtr:impact>Hosted meeting of the PSC patient group to discuss our research
Took on role as Trustee of the Charity in 2013

Asked to host the meeting on an annual basis
Helped develop a research funding programme for the charity
Helped write guieldlines and provide clinical advice</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.pscsupport.org.uk/?gclid=Cj0KEQiAp4yjBRCE_enjmpug944BEiQATCpLvU1wXwOybMo7BSFeWs_AEICLJAiyNnTvcfLZfY4HACIaApBA8P8HAQ</gtr:url><gtr:year>2009,2010,2011,2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>PPI initiatve</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>76B39E2D-E201-416B-A2C6-9F5A7DD41DA6</gtr:id><gtr:impact>20 members of the public and patients attended a seminar/workshop on liver research in Birmingham

Panel agreed to review our research patient information sheets</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010,2011,2012,2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Trustee PSC Support</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>68E7D925-5719-4AE4-A7E5-B0E414BC4FDE</gtr:id><gtr:impact>Trustee of patients support charity responsible for overseeing charity and organising meeting to share research advances</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:url>http://www.pscsupport.org.uk/?gclid=CjwKEAjwqZ7GBRC1srKSv9TV_iwSJADKTjaDl5WWgqCsixq9oG84SRlUY8FyF_2Um36QfNYcN2vUExoC8F7w_wcB</gtr:url><gtr:year>2015,2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Guardian</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DC357589-5CA6-4A5D-A0D0-745B4A27F782</gtr:id><gtr:impact>-Article in the Guardian on liver disease and transplantation www.guardian.co.uk/society/2008/nov/28/organ-donation-health-policy-transplant

Incraesed public profile</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public engagement</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F2234428-6791-4511-A423-A395A08EE3FA</gtr:id><gtr:impact>PSC Trust meeting London

Discussion of the potential for stem cell therapy in liver disease. A funding initiative to support genomics in liver disease.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Schools</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>62AEC61E-7573-4D02-B260-36B8F8E6E8D6</gtr:id><gtr:impact>-Students from local schools come to the department to learn about research and to carry out short projects

Goldcrest award and Nuffield Bursary award</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2007,2008,2009,2010,2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Efficacy and Mechanism Evaluation (EME) Programme</gtr:department><gtr:description>EME Project:12/165/31 - Targeting vascular adhesion protein-1 (VAP-1) for the treatment of liver fibrosis: a study of efficacy and mechanisms in patients with primary sclerosing cholangitis (PSC).</gtr:description><gtr:end>2019-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>EME  Project:12/165/31 - Targeting vascular adhesion protein-1 (VAP-1) for the treatment of liver fibrosis: a study of efficacy and mechanisms in patients with primary sclerosing cholangitis (PSC).</gtr:fundingRef><gtr:id>71CEB3C6-859E-4127-BEDE-93CEAD78751D</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>550000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC/NIHR EME</gtr:description><gtr:end>2019-02-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>EME Project:09/160/24 - A Phase II randomised clinical trial of conditioning cyclophosphamide and chemoembolisation with or without vaccination with dendritic cells pulsed with HepG2 lysate ex vivo in patients with Hepatocellular Carcinoma: IMMUNOTACE</gtr:fundingRef><gtr:id>4B24EE05-66A4-42BD-BEF8-DAC2BCEED38B</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/42FFE9FD-7EDF-4AAC-B107-C20FF7523021"><gtr:id>42FFE9FD-7EDF-4AAC-B107-C20FF7523021</gtr:id><gtr:title>Regulatory T cells and autoimmune hepatitis: defective cells or a hostile environment?</gtr:title><gtr:parentPublicationTitle>Journal of hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/736816f8f545c53af3577861e58e44cd"><gtr:id>736816f8f545c53af3577861e58e44cd</gtr:id><gtr:otherNames>Oo YH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0168-8278</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0BB9F426-83DB-430C-BC85-74974A777640"><gtr:id>0BB9F426-83DB-430C-BC85-74974A777640</gtr:id><gtr:title>Mucosal immunity in liver autoimmunity: a comprehensive review.</gtr:title><gtr:parentPublicationTitle>Journal of autoimmunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/15e68c617b011357137d3bb9f8bef859"><gtr:id>15e68c617b011357137d3bb9f8bef859</gtr:id><gtr:otherNames>Trivedi PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0896-8411</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/311477F4-9E35-46EF-9532-23A8BCBEE90C"><gtr:id>311477F4-9E35-46EF-9532-23A8BCBEE90C</gtr:id><gtr:title>Recruitment mechanisms of primary and malignant B cells to the human liver.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bd20de4d5c14af8cc708d7b67c01f07e"><gtr:id>bd20de4d5c14af8cc708d7b67c01f07e</gtr:id><gtr:otherNames>Shetty S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6D94FD0A-0FF0-41AF-A56D-97327ABB3412"><gtr:id>6D94FD0A-0FF0-41AF-A56D-97327ABB3412</gtr:id><gtr:title>Serum alkaline phosphatase in multidrug resistance 2 (Mdr2(-/-) ) knockout mice is strain specific.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/15e68c617b011357137d3bb9f8bef859"><gtr:id>15e68c617b011357137d3bb9f8bef859</gtr:id><gtr:otherNames>Trivedi PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1807AC1F-EE3A-43C2-B838-FB82BF7E00E7"><gtr:id>1807AC1F-EE3A-43C2-B838-FB82BF7E00E7</gtr:id><gtr:title>A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2e367a92edf320c5b0b28e09e11f0c97"><gtr:id>2e367a92edf320c5b0b28e09e11f0c97</gtr:id><gtr:otherNames>Palmer DH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BEEB6D20-8A5E-4B34-B966-BAA066B98399"><gtr:id>BEEB6D20-8A5E-4B34-B966-BAA066B98399</gtr:id><gtr:title>Cellular localization and trafficking of vascular adhesion protein-1 as revealed by an N-terminal GFP fusion protein.</gtr:title><gtr:parentPublicationTitle>Journal of neural transmission (Vienna, Austria : 1996)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1e6606ad68423212b7bb8721b236d8d3"><gtr:id>1e6606ad68423212b7bb8721b236d8d3</gtr:id><gtr:otherNames>Weston CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0300-9564</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CD8774D8-A606-4837-BCEA-45AF8C0B5153"><gtr:id>CD8774D8-A606-4837-BCEA-45AF8C0B5153</gtr:id><gtr:title>The regulation of T-cell recruitment to the human liver during acute liver failure.</gtr:title><gtr:parentPublicationTitle>Liver international : official journal of the International Association for the Study of the Liver</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6fb0670214d5bc63d29e42ea5eab49fb"><gtr:id>6fb0670214d5bc63d29e42ea5eab49fb</gtr:id><gtr:otherNames>Tuncer C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1478-3223</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AA82A9D6-69FD-4AF1-8820-36454FC03FD1"><gtr:id>AA82A9D6-69FD-4AF1-8820-36454FC03FD1</gtr:id><gtr:title>Bidirectional transendothelial migration of monocytes across hepatic sinusoidal endothelium shapes monocyte differentiation and regulates the balance between immunity and tolerance in liver.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ce6cfdd52bfbb5da8c46f2746e88cd27"><gtr:id>ce6cfdd52bfbb5da8c46f2746e88cd27</gtr:id><gtr:otherNames>Zimmermann HW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3FE412BB-4CDE-40CF-A1EA-AA53B30CAFDA"><gtr:id>3FE412BB-4CDE-40CF-A1EA-AA53B30CAFDA</gtr:id><gtr:title>Hepatic sinusoidal endothelium avidly binds platelets in an integrin-dependent manner, leading to platelet and endothelial activation and leukocyte recruitment.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Gastrointestinal and liver physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1206da15539ea3f88193f0cde366d1ac"><gtr:id>1206da15539ea3f88193f0cde366d1ac</gtr:id><gtr:otherNames>Lalor PF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0193-1857</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/75431333-D1DD-439F-B444-68386A3E15A8"><gtr:id>75431333-D1DD-439F-B444-68386A3E15A8</gtr:id><gtr:title>Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e2ec17573a7d601b84c252ca07eecde4"><gtr:id>e2ec17573a7d601b84c252ca07eecde4</gtr:id><gtr:otherNames>Liaskou E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/20714BE4-21F2-4FD4-9738-21E9CE38825A"><gtr:id>20714BE4-21F2-4FD4-9738-21E9CE38825A</gtr:id><gtr:title>Hepatic consequences of vascular adhesion protein-1 expression.</gtr:title><gtr:parentPublicationTitle>Journal of neural transmission (Vienna, Austria : 1996)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1e6606ad68423212b7bb8721b236d8d3"><gtr:id>1e6606ad68423212b7bb8721b236d8d3</gtr:id><gtr:otherNames>Weston CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0300-9564</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AE1A58EC-2C0E-4F2A-AE51-D61D118B566A"><gtr:id>AE1A58EC-2C0E-4F2A-AE51-D61D118B566A</gtr:id><gtr:title>Vascular adhesion protein-1 as a potential therapeutic target in liver disease.</gtr:title><gtr:parentPublicationTitle>Annals of the New York Academy of Sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1206da15539ea3f88193f0cde366d1ac"><gtr:id>1206da15539ea3f88193f0cde366d1ac</gtr:id><gtr:otherNames>Lalor PF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0077-8923</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1CF923D9-86F1-4802-BFE9-183473D3A34D"><gtr:id>1CF923D9-86F1-4802-BFE9-183473D3A34D</gtr:id><gtr:title>Mechanisms of immune-mediated liver injury.</gtr:title><gtr:parentPublicationTitle>Toxicological sciences : an official journal of the Society of Toxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/856c31f0b7d46b833b854dca3afb28a6"><gtr:id>856c31f0b7d46b833b854dca3afb28a6</gtr:id><gtr:otherNames>Adams DH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1096-0929</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0990B16D-EBA7-45D4-869E-FD55FA022D09"><gtr:id>0990B16D-EBA7-45D4-869E-FD55FA022D09</gtr:id><gtr:title>Activation of vascular adhesion protein-1 on liver endothelium results in an NF-kappaB-dependent increase in lymphocyte adhesion.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1206da15539ea3f88193f0cde366d1ac"><gtr:id>1206da15539ea3f88193f0cde366d1ac</gtr:id><gtr:otherNames>Lalor PF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/80C44060-F431-43D7-99E5-89FFDE04528D"><gtr:id>80C44060-F431-43D7-99E5-89FFDE04528D</gtr:id><gtr:title>Primary sclerosing cholangitis.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bb0cc0109e179d19fdeb7c8dc774a9c6"><gtr:id>bb0cc0109e179d19fdeb7c8dc774a9c6</gtr:id><gtr:otherNames>Hirschfield GM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/13A05276-CCDC-43B3-A381-FAC6BE9A1990"><gtr:id>13A05276-CCDC-43B3-A381-FAC6BE9A1990</gtr:id><gtr:title>CX(3)CR1 and vascular adhesion protein-1-dependent recruitment of CD16(+) monocytes across human liver sinusoidal endothelium.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4e8c9326e8cd06b12184818865d7651f"><gtr:id>4e8c9326e8cd06b12184818865d7651f</gtr:id><gtr:otherNames>Aspinall AI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/14561EED-2FC4-4481-89E0-3D394BC12508"><gtr:id>14561EED-2FC4-4481-89E0-3D394BC12508</gtr:id><gtr:title>Human hepatic sinusoidal endothelial cells can be distinguished by expression of phenotypic markers related to their specialised functions in vivo.</gtr:title><gtr:parentPublicationTitle>World journal of gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1206da15539ea3f88193f0cde366d1ac"><gtr:id>1206da15539ea3f88193f0cde366d1ac</gtr:id><gtr:otherNames>Lalor PF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1007-9327</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0700301</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D81A471F-556F-4570-BF6A-5D197943223C</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Oral and Gastrointestinal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>